Michael Feehan, PhD

 

Title: Visiting Professor

Office Address:

 

L. S. Skaggs Pharmacy Institute Room 4775
Phone: (801) 581-8054
Fax: (801) 587-7923
Email: Mike.Feehan@utah.edu

Profile:

Dr. Feehan is a former faculty member in the Department of Psychiatry at Harvard Medical School, and the CEO of Observant LLC, a specialist marketing science consulting firm.  He has a background in clinical psychology, developmental epidemiology, and marketing/health promotion science and strategy. He has extensive experience in large scale global quantitative survey research across many disease states using advanced predictive modeling techniques, and best-practice US and international qualitative research across multiple constituencies including patients/caregivers, health care professionals, and the C-suite.  In the Department of Pharmacotherapy, his research focuses on health systems reform and public health through optimizing pharmacy-related services to improve access, utilization, and medication adherence, particularly for disadvantaged populations.

Current Funded Research:

Munger, M., & Feehan, M. Co-Principal Investigators: “Research to Model the Demand for Primary Care Health Services in Community Pharmacies: A Linked Discrete Choice Model of Consumer, Pharmacist, and Payer Preferences.

Education:

  • Postdoctoral Fellow, Department of Mental Hygiene, Johns Hopkins Bloomberg School Public Health, 1995
  • Ph.D., Psychology, University of Otago, New Zealand, 1993
  • Dip.Cl.Ps., Clinical Psychology, University of Otago, New Zealand, 1988
  • M.Sc. (with Credit), Psychology, University of Otago, New Zealand, 1987
  • P.G.Dip.Sc., Psychology, University of Otago, New Zealand, 1986
  • B.Sc., Psychology, University of Otago, New Zealand, 1985

Select Recent Publications:

Quantitative:

  • Munger M, Ruble JH, Nelson SD, Ranker L, Petty RC, Silverstein S, Barton E, Feehan M. National Evaluation of Prescriber Drug Dispensing. Pharmacotherapy. 2014, Jul 23. doi: 10.1002/phar.1461. [Epub ahead of print]
  • Oderda GM, Shiozawa A, Walsh M, Hess K, Brixner DI, Feehan M, Akhras K. (2014) Physician Adherence to ACR Gout Treatment Guidelines: Perception vs. Practice. Postgraduate Medicine. 2014 May;126(3):257-267 (in partnership with Takeda).
  • Munger M, Eliot G, Hartman J, Vincent K, Feehan M. Community pharmacists’ occupational satisfaction and stress: a profession in jeopardy. J. Am. Pharm. Assoc. 2013;53:282-296
  • Feehan M, Hartman J, Durante R, Morrison MA, Miller JW, Kim IK, DeAngelis MM. Identifying Subtypes of Patients with Neovascular Age-Related Macular Degeneration by Genotypic and Cardiovascular Risk Characteristics. BMC Med. Genet. 2011;Jun 17;12:83.
  • Schluter PJ, Paterson J, & Feehan M. Prevalence and concordance of interpersonal violence reports from intimate partners: findings from the Pacific islands Families Study. J. Epidemiol. Community Health. 2007;61:625-630

 Qualitative:

  • Durante R, Casey B, Feehan M. The mutual blame game: how physicians and patient perceptions of non-adherence contribute to the problem. PBIRG Perspective. 2014, Spring 16(1), 12-14.
  • Durante R, Wong D, Griffen R, Feehan M. Doing More with Less: Leveraging Multi-Dimensional Modeling for Cost-Effective Global Research and Marketing Strategy. Marketing Insights. 2014, March: 29-33. (in partnership with Pfizer).
  • Wong D, Feehan M, Johnson D, Durante R, Ranker L. What marketers and researchers need to know about vaccines. Quirk’s Marketing Res. Rev., Feb 2014; Epub 20140225-2.
  • Durante R., Stark D, Feehan M. How do Oncologists Judge Potential Efficacy Thresholds for New Agents in Colorectal Cancer? PBIRG Perspective, Fall 2013;5(2):4-7
  • Wong D, Feehan M. Living with HIV as Older Adults – A Time of Promise? PBIRG Perspective, 2012, Spring 14(1),15-17.
  • Feehan M, Ilangakoon C, Mesure P. Three Steps to Clarity: A structured approach for qualitative verbatim analysis. Quirk’s Marketing Res. Rev. 2010;October:48-55.

Upcoming Events

View Calendar

IT Services

CPCSS - COMPUTER SUPPORT REQUEST

COMPUTER SUPPORT REQUEST